Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 4/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | ACACB | O00763 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30634254 | 1.00 | ALOX15 (0.43) | ALOX15HTTPSMD14HPGDSPDPK1 | |
| SCHEMBL23416636 | 0.80 | ALOX15 (0.49) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL10466162 | 0.77 | HTT (0.67) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL20173757 | 0.76 | ALOX15 (0.50) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL1353856 | 0.74 | ALOX15 (0.54) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL20118976 | 0.74 | ALOX15 (0.54) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL31250404 | 0.74 | ALOX15 (0.54) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL21882596 | 0.74 | ALOX15 (0.48) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL1351061 | 0.72 | HTT (0.52) | ALOX15HTTPSMD14HPGDSMAPK1 | |
| SCHEMBL20799517 | 0.72 | ALDH1A1 (0.62) | ALOX15HTTHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270187-A1 | MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY | THE SCRIPPS RESEARCH INSTITUTE | 2025-08-28 | — | — | US | disclosed |
| WO-2023212565-A2 | MOLECULAR EDITING OF MULTIPLE C-H BONDS BY LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270187-A1 | MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY | CYCS, CYC1, CDA | ALOX15 2814/4885HTT 70/4885PSMD14 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.